申请人:AJINOMOTO CO. INC
公开号:US20040002521A1
公开(公告)日:2004-01-01
The present invention provides an NF-kappa B activation inhibitor, an inflammatory cytokine production inhibitor, a matrix metalloprotease production inhibitor, an inflammatory cell adhesion factor expression inhibitor, and an anti-inflammatory agent, an antirheumatic agent, an immuno-suppressive agent, an antiallergic agent, an antiviral agent, or a therapeutic agent for arteriosclerosis, which comprise, as the active ingredient, a cyclopropanecarboxylic acid amide compound or a pharmaceutically acceptable salt thereof effective for the treatment of inflammatory diseases.
本发明提供了一种NF-kappa B激活抑制剂、炎性细胞因子产生抑制剂、基质金属蛋白酶产生抑制剂、炎性细胞黏附因子表达抑制剂、以及一种抗炎药、抗风湿药、免疫抑制剂、抗过敏药、抗病毒药或动脉粥样硬化治疗剂,其包括作为活性成分的环丙烷羧酸酰胺化合物或其药学上可接受的盐,用于治疗炎症性疾病。